2014
DOI: 10.1057/9781137375360
|View full text |Cite
|
Sign up to set email alerts
|

Brandjack

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…Etanercept has been reported as a potential treatment for palmoplantar pustulosis (Floristan 2011), even though palmoplantar pustulosis may paradoxically appear or worsen as a result of anti-TNF-α therapy for other inflammatory diseases (Rueda-Gotor 2012). Secukinumab is a human monoclonal antibody that targets IL-17A selectively and is highly e icacious in moderate to severe cases of plaque psoriasis (Langley 2014). Guselkumab is a fully human IgG1/λ monoclonal antibody that binds the p19 subunit of IL-23, thereby inhibiting binding of IL-23 to the receptor and subsequently inhibiting the Smoking cessation was associated with a significant reduction in pustule number (Michaëlsson 2006).…”
Section: How the Intervention Might Workmentioning
confidence: 99%
“…Etanercept has been reported as a potential treatment for palmoplantar pustulosis (Floristan 2011), even though palmoplantar pustulosis may paradoxically appear or worsen as a result of anti-TNF-α therapy for other inflammatory diseases (Rueda-Gotor 2012). Secukinumab is a human monoclonal antibody that targets IL-17A selectively and is highly e icacious in moderate to severe cases of plaque psoriasis (Langley 2014). Guselkumab is a fully human IgG1/λ monoclonal antibody that binds the p19 subunit of IL-23, thereby inhibiting binding of IL-23 to the receptor and subsequently inhibiting the Smoking cessation was associated with a significant reduction in pustule number (Michaëlsson 2006).…”
Section: How the Intervention Might Workmentioning
confidence: 99%
“…Etanercept has been reported as a potential treatment for palmoplantar pustulosis (Floristan 2011), even though palmoplantar pustulosis may paradoxically appear or worsen as a result of anti-TNF-α therapy for other inflammatory diseases (Rueda-Gotor 2012). Secukinumab is a human monoclonal antibody that targets IL-17A selectively and is highly e icacious in moderate to severe cases of plaque psoriasis (Langley 2014). Guselkumab is a fully human IgG1/λ monoclonal antibody that binds the p19 subunit of IL-23, thereby inhibiting binding of IL-23 to the receptor and subsequently inhibiting the Smoking cessation was associated with a significant reduction in pustule number (Michaëlsson 2006).…”
Section: How the Intervention Might Workmentioning
confidence: 99%
“…Furthermore, this shadow electorate includes a convincingly large cross-section of the population: Indeed, the number of Americans who regularly shop at Target is about the same as those who vote in US midterm elections. 115 This provides a brute force solution to the so-called "citizenship" objection that those affected by private rules should also help chose them. 116 Of course, real industries will usually contain admixtures of our end-states.…”
Section: Normative and Legal Implicationsmentioning
confidence: 99%